Top Geographic Atrophy Treatment companies

The 5 key players our Geographic Atrophy Treatment report profiles, and other companies free public records show in this market.

Key players in Geographic Atrophy Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Geographic Atrophy Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Geographic Atrophy Treatment, from free public records
CompanyWhere public records show them
Ocugen
Complement Therapeutics
Regeneron Pharmaceuticals
VisionCare, Inc.
Ray Therapeutics, Inc.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Geographic Atrophy Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Ocugen 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Complement Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Roche 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Annexon Biosciences 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Regeneron Pharmaceuticals 2 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Apellis Pharmaceuticals 2 active trials on ClinicalTrials.gov (opens in a new tab)
  7. VisionCare, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Ray Therapeutics, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Geographic Atrophy Treatment reports by place

All 33 places for Geographic Atrophy Treatment

Get the full Geographic Atrophy Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.